• No results found

Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder

N/A
N/A
Protected

Academic year: 2020

Share "Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder"

Copied!
7
0
0

Loading.... (view fulltext now)

Full text

Figure

Fig. 1 Study design
Table 1 PLACID study flow

References

Related documents

Secondary end- points included: (1) proportion of patients achieving CGI-I treatment response at 10, 20, 30, 40, 50, 60, 90, and 120 mins after dose one; (2) the number of patients